Technical Analysis for HROW - Harrow Health, Inc.

Grade Last Price % Change Price Change
grade D 5.66 -0.35% -0.02
HROW closed down 0.35 percent on Friday, November 15, 2019, on 1.18 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical HROW trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Inside Day Range Contraction 0.00%
Above Upper BB Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
200 DMA Resistance Bearish -0.35%
Slingshot Bearish Bearish Swing Setup -0.35%
Crossed Above 20 DMA Bullish -0.35%
Crossed Above 50 DMA Bullish -0.35%
MACD Bullish Signal Line Cross Bullish -0.35%

Older signals for HROW ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Harrow Health, Inc., formerly Imprimis Pharmaceuticals, Inc., is engaged in the development, production and dispensing of compounded pharmaceuticals. The Company operates through the business of developing drug therapies and providing such therapies through sterile and non-sterile pharmaceutical compounding services segment. The Company owns, markets and dispenses a portfolio of compounded therapeutic in several therapeutic areas, including ophthalmology, urology, otolaryngology and infectious diseases. The Company is also developing Custom Compounding Choice business, which is focused on developing and dispensing a portfolio of non-proprietary compounded drugs for humans and animals in therapeutic areas that may be overlooked by commercial pharmaceutical companies. The Company also offers customizable compounding products that consist of sterile injectable and non-sterile integrative medicine therapies that are used in various therapeutic areas.
Health Pharmaceutical Pharmaceuticals Infectious Diseases Pharmacy Pharmaceutical Industry In China Pharmaceutical Sciences Drug Therapies
Is HROW a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.99
52 Week Low 4.1
Average Volume 180,978
200-Day Moving Average 5.8968
50-Day Moving Average 5.3644
20-Day Moving Average 5.075
10-Day Moving Average 5.057
Average True Range 0.3238
ADX 20.72
+DI 29.551
-DI 16.3464
Chandelier Exit (Long, 3 ATRs ) 4.9386
Chandelier Exit (Short, 3 ATRs ) 5.5414
Upper Bollinger Band 5.5741
Lower Bollinger Band 4.5759
Percent B (%b) 1.09
BandWidth 19.668966
MACD Line -0.0275
MACD Signal Line -0.1053
MACD Histogram 0.0778
Fundamentals Value
Market Cap 113.56 Million
Num Shares 20.1 Million
EPS -0.81
Price-to-Earnings (P/E) Ratio -6.99
Price-to-Sales 1.39
Price-to-Book 4.30
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.20
Resistance 3 (R3) 6.17 5.97 6.11
Resistance 2 (R2) 5.97 5.83 5.98 6.08
Resistance 1 (R1) 5.81 5.74 5.71 5.84 6.05
Pivot Point 5.61 5.61 5.56 5.62 5.61
Support 1 (S1) 5.45 5.47 5.35 5.48 5.27
Support 2 (S2) 5.25 5.38 5.26 5.24
Support 3 (S3) 5.09 5.25 5.21
Support 4 (S4) 5.12